首页> 外文会议>European Solid-State Device Research Conference >Microfluidic technology: new opportunities to develop physiologically relevant in vitro models - Integrated microfluidic platform for the in vitro pre-implantation culture of individual mammalian embryos and their in situ characterization
【24h】

Microfluidic technology: new opportunities to develop physiologically relevant in vitro models - Integrated microfluidic platform for the in vitro pre-implantation culture of individual mammalian embryos and their in situ characterization

机译:微流体技术:在体外模型中开发生理相关的新机遇 - 用于个体哺乳动物胚胎的体外预植入培养物的集成微流体平台及其原位特征

获取原文

摘要

Here, we report the development of an integrated sensing platform for the field of assisted reproductive technologies (ART), and more specifically for the pre-implantation culture of mammalian embryos and their in situ characterization through evaluation of their metabolic activity. The entire platform consists of a nanoliter-culture chamber, with an integrated oxygen sensor to monitor the respiratory activity of individual embryos, as a marker for their viability and developmental competence. We first discuss the key-advantages of microfluidic technology to realize such an integrated sensing platform. We next present the culture device, and its validation on mouse embryos. This first stage validation reveals that microfluidics supports the full-term development of mouse embryos down to the single embryo level with birth rates comparable to group culture in conventional formats. In a second step, the device is upgraded for the culture of human embryos, and tested on donated frozen-thawed embryos. Finally, we describe an oxygen sensor consisting of an ultra-microelectrode array (UMEA) to be integrated in the culture device. Using this UME-based sensor, we also propose a novel measurement approach at short timescales, which allows reducing drastically the amount of oxygen consumed through the electrochemical measurements. Current work focuses on the integration of the sensor in the culture platform and its validation on biological materials. The integrated platform is currently tested on spheroids, which are used as surrogates of mammalian embryos, before it is applied on mouse embryos.
机译:在这里,我们报告综合检测平台的发展,为辅助生殖技术(ART)的领域,更特别为哺乳动物胚胎的胚胎植入前的文化和他们在原位表征通过其代谢活动的评价。整个平台由纳升培养室的,具有集成的氧传感器监视单个胚胎的呼吸活动,作为它们的生存力和发育能力的标记物。我们首先讨论微流控技术的关键优势,实现这种集成的传感平台。接下来,我们目前的培养装置,其对小鼠胚胎验证。这第一阶段的验证表明,微流控芯片支持完整的长远发展小鼠胚胎的下降与出生率媲美集团文化传统格式的单胚胎水平。在第二步骤中,该装置被用于升级人类胚胎的培养,并在捐赠冷冻解冻胚胎测试。最后,我们描述由超微电极阵列(UMEA)的氧传感器被集成在所述培养装置。使用这种基于UME传感器,我们还提出了在短时标,这允许显着地减少通过电化学测定消耗的氧的量的新的测量方法。当前的工作重点是培养底盘的传感器及其对生物材料验证的集成。集成的平台上的球状体,其被用作哺乳动物胚胎的替代物,对小鼠胚胎被施加之前,目前的测试。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号